Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DHODH-IN-17 is a human DHODH inhibitor with an IC50 of 0.40 μM. DHODH-IN-17 is a 2- anilino nicotinic acid that can be used in the study of acute myeloid leukemia (AML).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 105.00 | |
25 mg | In stock | $ 213.00 | |
50 mg | In stock | $ 318.00 | |
100 mg | In stock | $ 473.00 | |
500 mg | In stock | $ 987.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 68.00 |
Description | DHODH-IN-17 is a human DHODH inhibitor with an IC50 of 0.40 μM. DHODH-IN-17 is a 2- anilino nicotinic acid that can be used in the study of acute myeloid leukemia (AML). |
Targets&IC50 | DHODH:0.4 μM |
In vitro | DHODH-IN-17 inhibits human DHODH with an IC50 value of 0.40 μM.[1] |
Molecular Weight | 248.67 |
Formula | C12H9ClN2O2 |
CAS No. | 16344-26-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75.0 mg/mL (301.6 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DHODH-IN-17 16344-26-6 Metabolism Dehydrogenase inhibitor inhibit